DK0717635T3 - Fremgangsmåder til reduktion af gastrointestinal motilitet - Google Patents

Fremgangsmåder til reduktion af gastrointestinal motilitet

Info

Publication number: DK0717635T3
Authority: DK; Denmark
Prior art keywords: methods; gastrointestinal motility; reducing gastrointestinal; gastric emptying; reducing
Prior art date: 1993-09-07

Application number

DK94927398T

Other languages

Danish (da)

English (en)

Inventor

Orville G Kolterman

Andrew A Young

Timothy J Rink

Kathleen Keiting Brown

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-07

Filing date

1994-09-07

Publication date

2000-12-11

1994-09-07 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

2000-12-11 Application granted granted Critical

2000-12-11 Publication of DK0717635T3 publication Critical patent/DK0717635T3/da

Links

230000005176 gastrointestinal motility Effects 0.000 title 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract 1
102000036770 Islet Amyloid Polypeptide Human genes 0.000 abstract 1
108010041872 Islet Amyloid Polypeptide Proteins 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
239000008280 blood Substances 0.000 abstract 1
210000004369 blood Anatomy 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
230000030136 gastric emptying Effects 0.000 abstract 1
230000030135 gastric motility Effects 0.000 abstract 1
239000008103 glucose Substances 0.000 abstract 1
230000000291 postprandial effect Effects 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Diabetes (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Obesity (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Plant Substances (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK94927398T 1993-09-07 1994-09-07 Fremgangsmåder til reduktion af gastrointestinal motilitet DK0717635T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US11838193A	1993-09-07	1993-09-07
PCT/US1994/010225 WO1995007098A1 (en)	1993-09-07	1994-09-07	Methods for regulating gastrointestinal motility

Publications (1)

Publication Number	Publication Date
DK0717635T3 true DK0717635T3 (da)	2000-12-11

Family

ID=22378228

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94927398T DK0717635T3 (da)	1993-09-07	1994-09-07	Fremgangsmåder til reduktion af gastrointestinal motilitet

Country Status (23)

Country	Link
US (4)	US6114304A (de)
EP (1)	EP0717635B1 (de)
JP (2)	JP3821839B2 (de)
KR (2)	KR100429966B1 (de)
CN (1)	CN1134110A (de)
AT (1)	ATE197549T1 (de)
AU (1)	AU7685894A (de)
BG (1)	BG100463A (de)
BR (1)	BR9407424A (de)
CA (1)	CA2171207C (de)
CZ (1)	CZ69596A3 (de)
DE (1)	DE69426304T2 (de)
DK (1)	DK0717635T3 (de)
ES (1)	ES2154299T3 (de)
GR (1)	GR3035387T3 (de)
HU (1)	HUT73490A (de)
NO (1)	NO960899L (de)
PT (1)	PT717635E (de)
RU (1)	RU2177331C2 (de)
SG (1)	SG98356A1 (de)
SK (1)	SK31496A3 (de)
WO (1)	WO1995007098A1 (de)
ZA (1)	ZA946881B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5614492A (en) *	1986-05-05	1997-03-25	The General Hospital Corporation	Insulinotropic hormone GLP-1 (7-36) and uses thereof
US6849708B1 (en)	1986-05-05	2005-02-01	The General Hospital Corporation	Insulinotropic hormone and uses thereof
US7138486B2 (en)	1986-05-05	2006-11-21	The General Hospital Corporation	Insulinotropic hormone derivatives and uses thereof
HU222249B1 (hu) *	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
US6284727B1 (en)	1993-04-07	2001-09-04	Scios, Inc.	Prolonged delivery of peptides
BR9407424A (pt) *	1993-09-07	1996-04-09	Amylin Pharmaceuticals Inc	Métodos para regular motilidade gastrointestinal
US6143718A (en)	1995-06-07	2000-11-07	Amylin Pharmaceuticals, Inc.	Treatment of Type II diabetes mellutis with amylin agonists
DE69739172D1 (de) *	1996-08-08	2009-01-29	Amylin Pharmaceuticals Inc	Regulation gastrointestinaler beweglichkeit
PT1629849E (pt)	1997-01-07	2013-07-09	Amylin Pharmaceuticals Llc	Composições farmacêuticas que compreendem exendinas e seus agonistas
US7101853B2 (en)	1997-05-06	2006-09-05	Amylin Pharmaceuticals, Inc.	Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) *	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
US6936584B1 (en)	1998-02-13	2005-08-30	Amylin Pharmaceuticals, Inc.	Mixed amylin activity compounds
EP1053001B1 (de) *	1998-02-13	2010-12-15	Amylin Pharmaceuticals, Inc.	Neue verbindungen mit gemischter amylin aktivität
EP1658856B1 (de)	1999-01-14	2010-03-17	Amylin Pharmaceuticals, Inc.	Exendine zur Glucagon Suppression
CN101181236A (zh)	1999-01-14	2008-05-21	安米林药品公司	新型exendin激动剂制剂及其给药方法
US7399489B2 (en)	1999-01-14	2008-07-15	Amylin Pharmaceuticals, Inc.	Exendin analog formulations
US6924264B1 (en)	1999-04-30	2005-08-02	Amylin Pharmaceuticals, Inc.	Modified exendins and exendin agonists
US6528486B1 (en)	1999-07-12	2003-03-04	Zealand Pharma A/S	Peptide agonists of GLP-1 activity
US6451806B2 (en)	1999-09-29	2002-09-17	Adolor Corporation	Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en)	1999-11-29	2002-10-22	Adolor Corporation	Methods for the treatment and prevention of ileus
ES2440190T3 (es)	2000-03-03	2014-01-28	C. R. Bard, Inc.	Dispositivo endoscópico de aposición de tejido con múltiples puertos de succión
US7220266B2 (en)	2000-05-19	2007-05-22	C. R. Bard, Inc.	Tissue capturing and suturing device and method
US6451813B1 (en)	2001-01-26	2002-09-17	R. T. Alamo Ventures I, Llc	Treatment of gastroparesis in certain patient groups
JP2006510593A (ja) *	2002-09-12	2006-03-30	ザユニヴァーシティオヴシカゴ	胃内容排出及び胃不全麻痺のモニタリング及び診断
US8168233B2 (en) *	2002-10-18	2012-05-01	Amylin Pharmaceuticals, Inc.	Treatment of pancreatitis with amylin
US7655618B2 (en) *	2002-12-27	2010-02-02	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
NZ541365A (en) *	2002-12-27	2009-09-25	Diobex Inc	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20070275877A1 (en) *	2003-08-29	2007-11-29	Amylin Pharmaceuticals, Inc.	Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
DE602005021858D1 (de)	2004-02-11	2010-07-29	Amylin Pharmaceuticals Inc	Peptide der amylin familie, verfahren zu deren herstellung und verwendung
US7399744B2 (en) *	2004-03-04	2008-07-15	Amylin Pharmaceuticals, Inc.	Methods for affecting body composition
RU2433133C2 (ru) *	2004-03-09	2011-11-10	Майкробиа, Инк.	Полипептид для увеличения активности рецептора гуанилатциклазы, фармацевтическая композиция, способ лечения желудочно-кишечного расстройства у пациента, способ повышения активности рецептора гуанилатциклазы у пациента, способ лечения висцеральной боли, способ получения полипептида (варианты), изолированная молекула нуклеиновой кислоты, бактериальный вектор экспрессии и изолированная бактериальная клетка
US7878978B2 (en)	2004-03-18	2011-02-01	University Of Pittsburgh- Of The Commonwealth System Of Higher Education	Use of relaxin to increase arterial compliance
US8172857B2 (en)	2004-08-27	2012-05-08	Davol, Inc.	Endoscopic tissue apposition device and method of use
US8394765B2 (en) *	2004-11-01	2013-03-12	Amylin Pharmaceuticals Llc	Methods of treating obesity with two different anti-obesity agents
ES2325773T5 (es)	2004-11-01	2014-02-24	Amylin Pharmaceuticals, Llc.	Tratamiento de la obesidad y de los trastornos relacionados
US7671023B2 (en)	2005-03-31	2010-03-02	Amylin Pharmaceuticals, Inc.	Amylin agonist for treating depression, anxiety disorder and schizophrenia
US20090054305A1 (en)	2006-03-15	2009-02-26	Novo Nordisk A/S	Mixtures of Amylin and Insulin
AU2007230887A1 (en) *	2006-03-23	2007-10-04	Amylin Pharmaceuticals, Inc.	Endothelin and endothelin receptor agonists in the treatment of metabolic diseases
US20090181890A1 (en) *	2006-03-31	2009-07-16	Amylin Pharmaceuticals , Inc.	Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders
RU2314106C1 (ru) *	2006-07-07	2008-01-10	ФГОУ ВПО "Белгородская государственная сельскохозяйственная академия"	Способ угнетения моторной функции пищеварительного тракта
WO2008097536A2 (en)	2007-02-05	2008-08-14	Amylin Pharmaceuticals, Inc.	Compositions and methods for treating psychiatric diseases and disorders
KR20100098628A (ko) *	2007-11-14	2010-09-08	아밀린 파마슈티칼스, 인크.	비만 및 비만 관련 질환 및 장애의 치료 방법
KR101673042B1 (ko)	2009-03-12	2016-11-04	키바이오사이언스 아게	당뇨병 및 대사 증후군의 치료
US8748375B2 (en) *	2009-03-17	2014-06-10	Amylin Pharmaceuticals, Llc	Methods for affecting body composition using amylin agonists
CA2797133C (en)	2010-04-27	2019-08-06	Zealand Pharma A/S	Peptide conjugates of glp-1 receptor agonists and gastrin and their use
TW201326194A (zh)	2011-11-03	2013-07-01	Zealand Pharma As	Ｇｌｐ－１胃泌素受體促效劑肽結合物
MX356957B (es)	2012-07-23	2018-06-20	Zealand Pharma As	Analogos del glucagon.
TWI608013B (zh)	2012-09-17	2017-12-11	西蘭製藥公司	升糖素類似物
US9988429B2 (en)	2013-10-17	2018-06-05	Zealand Pharma A/S	Glucagon analogues
LT3057984T (lt)	2013-10-17	2018-12-27	Zealand Pharma A/S	Acilinti gliukagono analogai
KR102310392B1 (ko)	2013-11-06	2021-10-13	질랜드 파마 에이/에스	글루카곤-ｇｌｐ-1-ｇｉｐ 삼원 효능제 화합물
AU2014345569B2 (en)	2013-11-06	2020-08-13	Zealand Pharma A/S	GIP-GLP-1 dual agonist compounds and methods
WO2015196174A1 (en)	2014-06-20	2015-12-23	Greene Howard E	Infusion delivery devices and methods
RU2716985C2 (ru)	2014-10-29	2020-03-17	Зилэнд Фарма А/С	Соединения-агонисты gip и способы
EA035791B1 (ru)	2015-03-18	2020-08-11	Зилэнд Фарма А/С	Аналоги амилина
JP6989385B2 (ja)	2015-04-16	2022-01-05	ジーランドファーマアクティーゼルスカブ	アシル化グルカゴン類似体
AR109514A1 (es)	2016-09-09	2018-12-19	Zealand Pharma As	Análogos de amilina
SG10201911851VA (en)	2016-12-09	2020-02-27	Zealand Pharma As	Acylated glp-1/glp-2 dual agonists
EP3562500B1 (de)	2016-12-27	2023-07-19	Adocia	Zusammensetzungen in form einer injizierbaren wässrigen lösung mit amylin, einem amylin-rezeptor-agonist oder einem amylin-analogon und einer copolyaminosäure
PL3658115T4 (pl)	2017-07-27	2022-08-08	Adocia	Kompozycje w postaci wodnego roztworu do wstrzykiwań zawierające co najmniej insulinę ludzką a21g i co najmniej jeden supresor glukagonu o działaniu prandialnym
KR20240171194A (ko)	2017-12-07	2024-12-06	아도시아	아밀린, 아밀린 작용제 수용체 또는 아밀린 유사체 및 코-폴리아미노산을 포함하는 주사용 수용액 형태의 조성물
FR3083085B1 (fr)	2018-06-29	2020-10-02	Adocia	Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
EP3740195A1 (de)	2017-12-07	2020-11-25	Adocia	Zusammensetzungen in form einer injizierbaren wässrigen lösung mit amylin, einem amylin-rezeptor-agonist oder einem amylin-analogon und einer copolyaminosäure
FR3083086A1 (fr)	2018-06-29	2020-01-03	Adocia	Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
BR112020011479A2 (pt)	2017-12-07	2020-11-17	Adocia	composições na forma de uma solução aquosa injetável caracterizada pelo fato de que compreende amilina, um agonista do receptor de amilina ou um análogo de amilina e um co-poliaminoácido
WO2019115411A1 (fr)	2017-12-07	2019-06-20	Adocia	Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un co-polyaminoacide
FR3084586B1 (fr)	2018-08-03	2020-11-06	Adocia	Compositions sous forme d'une solution aqueuse injectable comprenant de l'amyline, un agoniste au recepteur de l'amyline ou un analogue d'amyline et un compose amphiphile porteur de radicaux hydrophobes
EP3930757A1 (de)	2019-03-01	2022-01-05	President And Fellows Of Harvard College	Verfahren und zusammensetzungen zur proteinabgabe
CA3237751A1 (en)	2021-11-10	2023-05-19	Tyler Brown	Ionic liquid compositions
WO2023136266A1 (ja) *	2022-01-11	2023-07-20	国立大学法人東京大学	食用魚の生産方法及び食用魚
MX2024005969A (es)	2022-05-30	2024-06-11	Zealand Pharma As	Formulaciones liquidas de analogos de amilina.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4451394A (en) *	1982-10-25	1984-05-29	American Home Products Corporation	Dodecapeptides preventing glucose and triglyceride assimilation
US4530838A (en) *	1983-07-08	1985-07-23	The Salk Institute For Biological Studies	Synthetic calcitonin-gene-related peptides for lowering blood pressure or gastric acid secretion in mammals
US4690486A (en) *	1985-04-29	1987-09-01	Texas Instruments Incorporated	Four position interlacing apparatus
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
GB8709871D0 (en) *	1987-04-27	1987-06-03	Turner R C	Peptides
US5367052A (en) *	1987-04-27	1994-11-22	Amylin Pharmaceuticals, Inc.	Amylin peptides
US5266561A (en) *	1988-01-11	1993-11-30	Amylin Pharmaceuticals, Inc.	Treatment of type 2 diabetes mellitus
US5175145A (en) *	1988-08-26	1992-12-29	Amylin Pharmaceuticals, Inc.	Treatment of diabetes mellitus with amylin agonists
US5166192A (en)	1989-05-09	1992-11-24	Mathias John R	Treatment of motility disorders with a GnRH analog
US5260275A (en) *	1990-08-14	1993-11-09	Amylin Pharmaceuticals, Inc.	Hypoglycemics
US5187154A (en) *	1990-12-13	1993-02-16	Board Of Regents, The University Of Texas System	Diagnosis and treatment of humans with diabetes or at risk to develop diabetes
US5264372A (en) *	1991-03-15	1993-11-23	Amylin Pharmaceuticals, Inc.	Receptor-based screening methods for amylin agonists and antagonists
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
HU222249B1 (hu) *	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
CA2109794A1 (en) *	1991-05-24	1992-11-26	Timothy J. Rink	Amylin and possibly insulin containing composition for the treatment of anorexia and related states
US5580953A (en) *	1991-08-14	1996-12-03	Amylin Pharmaceuticals, Inc.	Amylin antagonist peptides and uses therefor
MD960317A (ro) *	1991-11-19	1998-05-31	Anylin Pharmaceuticals, Inc.	Noile peptide-agoniste ale amilinei şi utilizarea lor
US5376638A (en) *	1992-09-01	1994-12-27	Amylin Pharmaceuticals, Inc.	Methods for treating renin-related disorders with amylin antagonists
WO1994020116A1 (en) *	1993-03-10	1994-09-15	University Of Alabama Research Foundation	Artificial primers for glycogen synthesis
BR9407424A (pt) *	1993-09-07	1996-04-09	Amylin Pharmaceuticals Inc	Métodos para regular motilidade gastrointestinal
US6143718A (en) *	1995-06-07	2000-11-07	Amylin Pharmaceuticals, Inc.	Treatment of Type II diabetes mellutis with amylin agonists

1994
- 1994-09-07 BR BR9407424A patent/BR9407424A/pt not_active Application Discontinuation
- 1994-09-07 WO PCT/US1994/010225 patent/WO1995007098A1/en not_active Ceased
- 1994-09-07 AU AU76858/94A patent/AU7685894A/en not_active Abandoned
- 1994-09-07 HU HU9600558A patent/HUT73490A/hu unknown
- 1994-09-07 ES ES94927398T patent/ES2154299T3/es not_active Expired - Lifetime
- 1994-09-07 EP EP94927398A patent/EP0717635B1/de not_active Expired - Lifetime
- 1994-09-07 AT AT94927398T patent/ATE197549T1/de active
- 1994-09-07 SK SK314-96A patent/SK31496A3/sk unknown
- 1994-09-07 KR KR10-2003-7005868A patent/KR100429966B1/ko not_active Expired - Lifetime
- 1994-09-07 CN CN94193931A patent/CN1134110A/zh active Pending
- 1994-09-07 DE DE69426304T patent/DE69426304T2/de not_active Expired - Lifetime
- 1994-09-07 KR KR1019960701160A patent/KR100391399B1/ko not_active Expired - Lifetime
- 1994-09-07 US US08/302,069 patent/US6114304A/en not_active Expired - Lifetime
- 1994-09-07 DK DK94927398T patent/DK0717635T3/da active
- 1994-09-07 ZA ZA946881A patent/ZA946881B/xx unknown
- 1994-09-07 RU RU96107891/14A patent/RU2177331C2/ru active
- 1994-09-07 CZ CZ96695A patent/CZ69596A3/cs unknown
- 1994-09-07 JP JP50882395A patent/JP3821839B2/ja not_active Expired - Lifetime
- 1994-09-07 CA CA2171207A patent/CA2171207C/en not_active Expired - Lifetime
- 1994-09-07 SG SG9607979A patent/SG98356A1/en unknown
- 1994-09-07 PT PT94927398T patent/PT717635E/pt unknown
1995
- 1995-06-05 US US08/471,675 patent/US5795861A/en not_active Expired - Lifetime
1996
- 1996-03-06 NO NO960899A patent/NO960899L/no unknown
- 1996-03-29 BG BG100463A patent/BG100463A/xx unknown
2000
- 2000-05-22 US US09/576,062 patent/US6608029B1/en not_active Expired - Fee Related
2001
- 2001-02-07 GR GR20010400214T patent/GR3035387T3/el unknown
2003
- 2003-08-18 US US10/643,681 patent/US7407934B2/en not_active Expired - Fee Related
2004
- 2004-08-11 JP JP2004234571A patent/JP2004331674A/ja active Pending

Also Published As

Publication number	Publication date
BR9407424A (pt)	1996-04-09
RU2177331C2 (ru)	2001-12-27
HUT73490A (en)	1996-08-28
CA2171207A1 (en)	1995-03-16
PT717635E (pt)	2001-04-30
WO1995007098A1 (en)	1995-03-16
EP0717635B1 (de)	2000-11-15
HU9600558D0 (en)	1996-05-28
US6114304A (en)	2000-09-05
KR100429966B1 (ko)	2004-05-04
CA2171207C (en)	2010-03-30
CZ69596A3 (en)	1997-06-11
DE69426304T2 (de)	2001-03-15
SK31496A3 (en)	1998-06-03
ES2154299T3 (es)	2001-04-01
ATE197549T1 (de)	2000-12-15
DE69426304D1 (de)	2000-12-21
US5795861A (en)	1998-08-18
AU7685894A (en)	1995-03-27
GR3035387T3 (en)	2001-05-31
SG98356A1 (en)	2003-09-19
BG100463A (en)	1997-03-31
US6608029B1 (en)	2003-08-19
NO960899D0 (no)	1996-03-06
NO960899L (no)	1996-05-06
KR20040004418A (ko)	2004-01-13
US7407934B2 (en)	2008-08-05
CN1134110A (zh)	1996-10-23
EP0717635A1 (de)	1996-06-26
JP3821839B2 (ja)	2006-09-13
JP2004331674A (ja)	2004-11-25
US20040097415A1 (en)	2004-05-20
JPH09502443A (ja)	1997-03-11
KR100391399B1 (ko)	2004-02-11
ZA946881B (en)	1995-10-30

Publication	Publication Date	Title
NO960899L (no)	1996-05-06	Fremgangsmåte for regulering av gastrointestinal motilitet
CA2262647A1 (en)	1998-02-12	Methods for regulating gastrointestinal motility
CY1107752T1 (el)	2013-04-18	Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης
NZ504258A (en)	2002-12-20	Exendin 3 and 4 agonist compounds for the treatment of diabetes
BR9814189A (pt)	2000-10-03	"compostos agonistas da exendina"
BG101278A (bg)	1997-12-30	Твърди системи за контролирано освобождаване и методи за получаването им
NO976063L (no)	1998-02-16	Fremgangsmåte for behandling av diabetes
ATE234092T1 (de)	2003-03-15	2-alkylpyrrolidine
DE69910045D1 (de)	2003-09-04	Neue heteroaromatische fructose 1,6-bisphosphatase inhibitoren
CY1110894T1 (el)	2015-06-10	Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης
PL328858A1 (en)	1999-03-01	Immunogenous peptides
IE800102L (en)	1980-07-19	N-benzylimidazoles
WO1997040072A3 (en)	1998-03-26	Adam proteins and uses thereof
CA2340320A1 (en)	2000-03-16	Use of an angiogenic factor for the treatment of microascular angiopathies
CY1106656T1 (el)	2012-01-25	Χρηση ελαστασης για διανοιξη αποφραγμενων αρτηριων και φλεβων
ATE543451T1 (de)	2012-02-15	Bioabsorbierbare, osteogenetische knochenplatte
UA50761C2 (uk)	2002-11-15	Спосіб запобігання та/або лікування серцевих захворювань, фармацевтична композиція та спосіб запобігання та/або лікування серцевої недостатності та дисфункції шлуночків в організмі теплокровної тварини
AU3439799A (en)	1999-11-23	Immunization against and treatment for infection by (h.pylori)
NO894008L (no)	1990-04-17	Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
EP1417971A3 (de)	2004-06-30	Verwendung eines angiogenen Faktors zur Behandlung von mikrovaskulären Angiopathien
PL354961A1 (en)	2004-03-22	Prevention and treatment of diseases associated with blood coagulation
TR199802496T2 (xx)	1999-02-22	Konjestif kalp yetmezli�ini tedavi i�in form�lasyon.
DK0979098T3 (da)	2003-07-14	Fremgangsmåde til behandling af hyperprolaktinæmi og prolaktinomer
RU2002112556A (ru)	2004-01-20	Способ лечения мужского бесплодия
UA29280A (uk)	2000-10-16	Спосіб лікування флегмони шлунку